---
figid: PMC3978385__nihms-570892-f0004
figtitle: 'NRAS mutant melanoma: biological behavior and future strategies for therapeutic
  management'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
pmcid: PMC3978385
filename: nihms-570892-f0004.jpg
figlink: /pmc/articles/PMC3978385/figure/F4/
number: F4
caption: A. Typically, NRAS mutant melanomas rely on CRAF-mediated MAPK activation,
  with BRAF locked into an inactive conformation. B. BRAF inhibitors relieve the auto-inhibition
  of BRAF leading to its recruitment to the plasma membrane. This then leads to the
  dimerization of BRAF and CRAF leading to enhanced MAPK pathway signaling and proliferation.
papertitle: 'NRAS mutant melanoma: biological behavior and future strategies for therapeutic
  management.'
reftext: Inna V. Fedorenko, et al. Oncogene. ;32(25):3009-3018.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9605516
figid_alias: PMC3978385__F4
figtype: Figure
redirect_from: /figures/PMC3978385__F4
ndex: de7329e6-dea9-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3978385__nihms-570892-f0004.html
  '@type': Dataset
  description: A. Typically, NRAS mutant melanomas rely on CRAF-mediated MAPK activation,
    with BRAF locked into an inactive conformation. B. BRAF inhibitors relieve the
    auto-inhibition of BRAF leading to its recruitment to the plasma membrane. This
    then leads to the dimerization of BRAF and CRAF leading to enhanced MAPK pathway
    signaling and proliferation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Ras64B
  - Ras85D
  - Dsor1
  - Mtk
  - Erk7
  - rl
---
